Skip to main content
. 2021 Jul 21;2:685236. doi: 10.3389/froh.2021.685236

Figure 3.

Figure 3

Cancer stem cell-directed therapies in HNSCC. Selected anti-CSC drugs currently under clinical investigation. Their mechanisms of actions include targeting CSC-associated surface markers and CSC-associated signaling pathways, including developmental pathways, that regulate the maintenance, and survival of CSCs.